Table: Kobayashi Pharmaceutical -Q1 group results
May 10 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2024 Mar 31, 2023 Dec 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 36.49 33.47
(+9.0 pct) (+2.5 pct)
Operating 5.03 5.06
(-0.6 pct) (+4.5 pct)
Recurring 5.46 5.17
(+5.7 pct) (+1.3 pct)
Net 976 mln 3.61
(-72.9 pct) (+3.9 pct)
EPS 13.13 yen 47.43 yen
Ann Div 101.00 yen 103.00 yen
-Q2 div 43.00 yen 44.00 yen
-Q4 div 58.00 yen 59.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows